Health-related quality of life and virologic outcomes in an HIV clinic

Quality of Life Research

Volumn 9, Issue 9, 2000, Pages 977-985

  Call, S A ^a   Klapow, J C ^b,c   Stewart, K E ^d,e   Westfall, A O ^f   Mallinger, A P ^b   DeMasi, R A ^g   Centor, R ^h   Saag, M S ^d  

^a Veterans Administration   (United States)

^b Department of Health Care Organization and Policy ^*  (United States)

^c Center for Outcomes and Effectiveness Research and Education   (United States)

^d Division of Infectious Diseases   (United States)

^e Division of Preventive Medicine   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g GLAXOSMITHKLINE   (United States)

^h Division of General Internal Medicine   (United States)

Author keywords

AIDS; Health related quality of life; HIV; SF 36

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; FEMALE; HEALTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; VIRUS LOAD;

ADULT; ALABAMA; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MULTIVARIATE ANALYSIS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; VIRAL LOAD;

EID: 0034457177     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016668802328     Document Type: Article

References (55)

1. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection
2. Current antiretroviral therapy: An overview
3. Monitoring plasma HIV-1 RNA levels in addition to CD4 lymphocyte count improves assessment of antiretroviral therapeutic response
4. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
5. Plasma viral load and CD4 lymphocytes as prognostic markers of HIV-1 infection
6. Changes in plasma HIV-1 RNA and CD4 lymphocyte counts and the risk of progression to AIDS
7. Changes in plasma HIV RNA levels and CD4 lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure
8. From the centers for disease control and prevention. Update: Trends in AIDS incidence - US, 1996
9. Treatment with indinavir, zidovudine and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
10. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
11. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
12. Comparison of the quality of well-being scale and the SF-36 results among two samples of ill adults: AIDS and other illnesses
13. The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population
14. Health-related quality of life of HIV-infected women: Evidence for the reliability, validity and responsiveness of the medical outcomes study short-form 20
15. Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire
16. SF-20 score and item distributions in a human immunodeficiency virus-seropositive sample
17. Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning
18. An overview of generic health-related quality of life measures for HIV research
19. Applications of the medical outcomes study health-related quality of life measures in HIV/AIDS
20. Quality of life in persons with human immunodeficiency virus infection: Measurement by the medical outcomes study instrument
21. Change in clinical status, health status, and health utility outcomes in HIV-infected patients
22. Quality of life as a function of HIV classification
23. Derivation and properties of a brief health status assessment instrument for use in HIV disease
24. The concurrent validity of items in the quality-of-life index in a cohort of HIV-positive and HIV-negative gay men
25. Construct validities of the quality of well-being scale and the MOS-HIV-34 health survey for HIV-infected patients
26. The quality of well-being scale in asymptomatic HIV-infected patients
27. The use of two measures of health-related quality of life in HIV-infected individuals: A cross-sectional comparison
28. Validity of the quality of well-being scale for persons with human immunodeficiency virus infection
29. Reliability and validity of an HIV-specific health-related quality-of-life measure for use with injecting drug users
30. Toward a better understanding of health-related quality of life: A comparison of the Medical Outcomes Study HIV Health Survey (MOS-HIV) and the HIV Overview of Problems-Evaluation System (HOPES)
31. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV)
32. The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDS
33. Responsiveness of the EuroQol and MOS-HIV in advanced HIV disease
34. Measuring quality of life from the point of view of HIV-positive subjects: The HIV-QL31
35. Performance of a new, HIV/AIDS-targeted quality of life (HAT-QoL) instrument in asymptomatic seropositive individuals
36. A new HIV/AIDS-targeted quality of life (HAT-QoL) instrument: Development, reliability, and validity
37. Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument
38. Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument
39. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection
40. Reliability and validity of physical and mental health summary scores from the medical outcomes study HIV health survey
41. Assessment of quality of life in early stage HIV-infected persons: Data from the AIDS Time-oriented Health Outcome Study (ATHOS)
42. Changes in quality of life among persons with HIV infection
43. Measuring health-related quality of life among patients infected with human immunodeficiency virus
44. Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease
45. Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey
46. A study of the reliability, validity and responsiveness of the HIV overview of problems evaluation system (HOPES) in assessing the quality of life of patients with AIDS and symptomatic HIV infection
47. Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients
48. A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients
49. The MOS 36 item short form health survey (SF-36): I. Conceptual framework and item selection
50. The reliability and validity of two HIV-specific health-related quality-of-life measures: A preliminary analysis
51. Defining and measuring quality of life in medicine
52. Health status among persons infected with human immunodeficiency virus. A community-based study